Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs
(Q58043487)
scientific article published on 01 December 1997
scientific article published on 01 December 1997
Language:
Current Data About
Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs
other details
| description | scientific article published on 01 December 1997 |
External Links
| (P356) |
10.1093/RHEUMATOLOGY/36.12.1298
|
| (P698) |
9448591
|